256 related articles for article (PubMed ID: 33589745)
1. Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients.
Chen L; Abou-Alfa GK; Zheng B; Liu JF; Bai J; Du LT; Qian YS; Fan R; Liu XL; Wu L; Hou JL; Wang HY;
Cell Res; 2021 May; 31(5):589-592. PubMed ID: 33589745
[No Abstract] [Full Text] [Related]
2. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
[TBL] [Abstract][Full Text] [Related]
3. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
4. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
Waqar W; Asghar S; Manzoor S
PLoS One; 2021; 16(9):e0256739. PubMed ID: 34469466
[TBL] [Abstract][Full Text] [Related]
5. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
7. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
8. From genome sequencing to the discovery of potential biomarkers in liver disease.
Oh S; Jo Y; Jung S; Yoon S; Yoo KH
BMB Rep; 2020 Jun; 53(6):299-310. PubMed ID: 32475383
[TBL] [Abstract][Full Text] [Related]
9. Cell-specific functions of miRNA in the liver.
Roderburg C; Trautwein C
J Hepatol; 2017 Mar; 66(3):655-656. PubMed ID: 27702640
[No Abstract] [Full Text] [Related]
10. DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.
Hassouna MM; Naguib M; Radwan EM; Abdel-Samiee M; Estaphan S; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3357-3363. PubMed ID: 33247696
[TBL] [Abstract][Full Text] [Related]
11. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
Abdelgawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
Asian Pac J Cancer Prev; 2013; 14(12):7345-9. PubMed ID: 24460300
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma.
Huang Z; Hua D; Hu Y; Cheng Z; Zhou X; Xie Q; Wang Q; Wang F; Du X; Zeng Y
Pathol Oncol Res; 2012 Apr; 18(2):271-6. PubMed ID: 21779787
[TBL] [Abstract][Full Text] [Related]
13. Detecting Liver Cancer Using Cell-Free DNA Fragmentomes.
Foda ZH; Annapragada AV; Boyapati K; Bruhm DC; Vulpescu NA; Medina JE; Mathios D; Cristiano S; Niknafs N; Luu HT; Goggins MG; Anders RA; Sun J; Meta SH; Thomas DL; Kirk GD; Adleff V; Phallen J; Scharpf RB; Kim AK; Velculescu VE
Cancer Discov; 2023 Mar; 13(3):616-631. PubMed ID: 36399356
[TBL] [Abstract][Full Text] [Related]
14. Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
[TBL] [Abstract][Full Text] [Related]
15. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies.
Gonçalves E; Gonçalves-Reis M; Pereira-Leal JB; Cardoso J
Sci Rep; 2022 Jul; 12(1):11512. PubMed ID: 35798798
[TBL] [Abstract][Full Text] [Related]
17. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma.
Liu XF; Thin KZ; Ming XL; Shuo-Li ; Ping-Luo ; Man-Zhu ; Li ND; Tu JC
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794494. PubMed ID: 30126319
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma.
Samdanci ET; Akatli AN; Soylu NK
J Gastrointest Cancer; 2020 Dec; 51(4):1187-1192. PubMed ID: 32860202
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]